BF BFLY Butterfly Network, Inc. Loading... : Bullish and Bearish Analyst Opinions

Author highlights a basket of names showing relative strength that he brought higher on his focus list, but this is a momentum watchlist rather than an explicit position or forward call.

Author lists names showing relative strength that moved higher on their focus list, a watchlist update without explicit position language or forward call.

Butterfly Network has promising handheld ultrasound/MRI technology, fell from $20 to $8, can be bought a little lower as a speculative position with no major flaws.

Butterfly Network's ultrasound chips are explicitly named as the sensor technology powering Midjourney's 500,000-emitter full-body scanner. This validates their chip technology for a high-volume, non-diagnostic medical application and could open a new revenue stream if Midjourney scales to 50,000 scanners by 2031. Risk: Midjourney's scanner is still a prototype; FDA approval path is narrow and long. BFLY's revenue concentration risk if Midjourney is the sole customer for this application.

Butterfly Network (BFLY) builds the ultrasound-on-chip technology that packs thousands of transducer elements into a single semiconductor die. Midjourney just launched a full-body medical scanner and is licensing Butterfly's technology and buying its chips. The deal gives Butterfly three revenue streams: a fixed license ($15M upfront plus $10M/year over 5 years), chip sales (the real volume lever—each scanner uses a dense multi-row ring of chips, potentially 15-50 thousand in silicon per unit), and a revenue share tied to hardware. Revenue would land about 10-70% above today's level. The stock pumped 56% on the announcement.

The author notes that Butterfly Network's 10x daily volume is unusual but does not state a personal position or forward call, so it is indexed as a watch.

Buy BFLY as the underlying hardware supplier to Midjourney's body scanner: 40 Ultrasound-on-Chip modules per unit, a $74M licensing deal over five years, and Midjourney targeting 50,000 scanners with per-unit royalties accruing to BFLY at scale.

Author highlights $BFLY in context of Midjourney's full-body ultrasound scanner announcement, which leverages Butterfly's ultrasound-on-chip platform via a licensing deal disclosed November 2025 worth up to $74M; management presented at TD Cowen conference same day.